SomnoMed Limited
SomnoMed Limited is globally recognized as the world’s leading oral device company, manufacturing and designing a premium range of oral devices for the treatment of disturbed sleep. Established in 2004 following 7 years of clinical research Somnomed launched the MAS gold standard for the treatment of Obstructive Sleep Apnea, the SomnoDent. A patented, clinically validated and compliant alternative to that of upper airway surgery and CPAP; SomnoDent offers reduced bulkiness, no tongue space restriction and can be incrementally titrated for increased effectiveness. SomnoDent enables uncompromised speech, the ability to yawn and drink water while wearing the device, making it the market leader in terms of design, comfort, efficacy and compliance. Additionally, the launch of our new SMH BFlex lining for the SomnoDent FLEX gives the device an even better look and feel with unmatched retention.
In line with our evidenced based approach, SomnoMed continues to conduct research and development projects to provide further clinical evidence, and to better serve our patients and our network of accredited Dental Sleep Professional.
With 30,000 patients under SomnoDent therapy worldwide we have now expanded our product portfolio to include the addition of SomBrux, a customizable occlusal splint for the treatment of sleep related bruxism. SomBrux utilizes SomnoMed’s exclusive SMH BFlex material and complies with the unmatched quality synonymous with all SomnoMed products. SomBrux is a demand driven natural evolution of our dental sleep appliance range.
While we manufacture potentially life changing devices, it is via the multidisciplinary network of health care professionals including dentists, Sleep Specialists and Ear Nose and Throat Surgeons that ensures patients under SomnoMed device therapy are treated thoroughly, and in line with our evidence-based approach. Through these values we aim to provide reliable support to patients, dentists and referring specialists in our shared quest to alleviate the strain of sleep disorders on the community.
